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1. Introduction {#sec1}
===============

Recently, Zika virus infection has become a dangerous threat for the human society ([@bib8]; [@bib28]). It is a vector borne disease, spreads through the mosquito borne flavi-virus. In the beginning, the infection transmitted to the human body by the bites of infected *Aedes aegypti* female mosquitoes, which also transmit the dengue, chikungunya, yellow fever, Japanese Encepalitie's virus ([@bib16]; [@bib38]) widely in the tropical and subtropical regions. Symptoms of Zika infection are normally mild, including fever, headaches, rash, conjunctivitis and joint pain due to flavi-virus. Zika infection increases the chances of microcephaly (permanent disabilities) Guillain-Barre syndrome and other neurological disorder in newborn babies from infected mothers ([@bib8]; [@bib28]).

This virus was first identified from rhesus monkeys in 1947 in the Zika forest of Uganda ([@bib12]; [@bib35]) and from humans in Nigeria in 1954 ([@bib12]; [@bib25]; [@bib34], pp. 477--500) but it was not spread in epidemic form among the human population until 2007 ([@bib16]; [@bib13]). The first Zika outbreak among human occurred in Yap Island, Micronesia in 2007 ([@bib16]; [@bib13]; [@bib26]). Afterward, this disease highly spread among human in a different country. First Zika virus, epidemic occurred in French Polynesia in the year 2013--2014 ([@bib19]). After 2015, it is spreading rapidly worldwide. The country Brazil, Southern and Central American as well as in Caribbean, countries are highly affected by Zika. World Health Organisation declared Zika as "public health emergency of the international 2016. According to Pan American Health Organisation (PAHO) and WHO, 583451 suspected and 223477 confirmed cumulative Zika cases were reported up to 04 January 2018 by countries and territories in the Americans among which the respective cases for Brazil are 231725 and 137288 respectively.

Recent studies showed that Zika virus can be transmitted not only by vector only, it also spread by sexual interaction which was reported in ([@bib17]; [@bib11]; [@bib9]; [@bib36]; [@bib29]). A remarkable observation was given by the authors in ([@bib29]) reported that though Zika virus was disappeared from the blood of an infected person even then it was present in his semen, which point out the possibility of sexual transmission of the Zika virus.

Though Zika infection is a threat for public health, but at present no vaccination is available to protect from Zika infection and no particular treatment, medicine or fast diagnostic test is available to treat or diagnose this infection. Thus human awareness through health programs and control of mosquitoes through insecticides is the two effective ways to prevent its infection transmission among the host population.

In the last few years, a number of mathematical models have been reported ([@bib1], [@bib2]; [@bib4]; [@bib5]; [@bib22]; [@bib23]; [@bib30]; [@bib33]) to study the Zika virus transmission dynamics. In those models, the investigators have incorporated the following factors, (i) both vector and sexual transmission ([@bib1], [@bib2]; [@bib33]), (ii) both vector and sexual transmission route with bilinear incidence rate and they established the backward bifurcation and the global stability of DFE for the same model, but in a single model backward bifurcation and the global stability of DFE are contradictory to each other. (iii) the vertical transmission and vector transmission ([@bib1], [@bib2]; [@bib22]) and (iv) optimal control on spraying insecticides, other prevention, and treatment ([@bib5]; [@bib31]; [@bib33]). The impact of awareness on dengue dynamics has been studied by Gakkhar and Chavda ([@bib18]).

In order to study the impact of human awareness and vector control, we construct a Zika model including both vector and sexual transmission route, we also include the human awareness ([@bib27]) and vector control. In this work, we have established the wellposedness, positivity and boundedness, the local and global stability of the DFE and the existence and local stability of endemic equilibrium (EE). Finally, we have validated and estimated the model parameters of the considered model comparing the model predictions with the reported zika infected data of a particular area. To explore the model robustness to parameter values used we investigate the sensitivity analysis using the normalised forward sensitivity index. We also studied numerically the impact of sexual transmission on the epidemic growth rate as well as on the basic reproduction number. To the best of our knowledge effect of vector transmission, sexual transmission, vector control, and human awareness has not yet been considered in a single Zika model. So in this paper, we are considering all these four important facts to propose a Zika model and intend to study its dynamical behaviour.

The rest of the paper is organized as follows: The formulation and basic properties of the model have been described in section-2. An investigation of the stability and bifurcation of the model has been reported in section-3. Parameter estimation and model validation done by simulating the model with reported real data done in section-4. Sensitivity analysis of the model is presented in section-5 and section-6 deals with the effect of sexual transmission on basic reproduction number and epidemic growth rate numerically. Finally, all the results have been concluded in the section-7.

2. Model formulation {#sec2}
====================

Let the total human population $N_{h}\left( t \right)$ is classified into four compartments comprised of susceptible human $S_{h}\left( t \right)$, exposed human $E_{h}\left( t \right)$, infected human $I_{h}\left( t \right)$ and recovered human$R_{h}\left( t \right)$. Here we have considered that a human individual who recovered from infection of Zika virus gain lifelong immunity from it. Sine only female mosquito spreads the zika infection so the total female mosquito population $N_{v}\left( t \right)$ is divided into three compartments viz. susceptible mosquitoes $S_{v}\left( t \right)$, exposed mosquitoes $E_{v}\left( t \right)$ and infected mosquitoes $I_{v}\left( t \right)$. Again recovery of mosquito from Zika infection is not taken into consideration due to its short life span.

To formulate the model the following factors are taken into consideration:(i)Constant recruitment rate for both susceptible human and vector population.(ii)Natural death rate for both human and vector population.(iii)Horizontal transmission of infection from infected vectors to susceptible human when infected vectors bite susceptible human.(iv)Sexual transmission of infection to susceptible human when a susceptible human interact sexually with an infected human.(v)Horizontal transmission of infection from infected human to susceptible vectors when susceptible vectors bite infected human.(vi)Two steps of human awareness has considered. At a constant rate susceptible human can take following awareness steps to protect them from zika (a) using mosquito-nets, and mosquito repellents (b) avoiding sexual interaction or using a condom at the period of zika out break.(vii)Vector control: spray of insecticide and removal of the stagnant water can control vector.

Let, $\pi$ be the constant recruitment rate of susceptible human and $\mu$ be the natural death rate of the human population. Suppose, susceptible individuals acquire infection due to effective contact with an infected vector at rate $\lambda_{1} = \frac{b_{2}\alpha_{1}I_{v}}{N_{h}}$ , $\lambda_{2} = \frac{c\alpha_{2}I_{h}}{N_{h}}$ be the infection due to sexual interaction with the infected individuals and susceptible human become aware at a constant rate $a$ and enter into recovered class $R_{h}$. So the total infection strength of human is $\lambda_{h} = \lambda_{1} + \lambda_{2}$.Here we assume that the susceptible mosquitoes acquire infection at a rate $\lambda_{v}S_{v}$ from infected human where $\lambda_{v} = \frac{b_{2}\alpha_{3}I_{h}}{N_{h}}$.

Under the above assumptions, the flow diagram for both human population and vector population of the proposed zika model is given in the following flow diagram (see [Fig. 1](#fig1){ref-type="fig"}).Fig. 1Flow diagram of Zika virus in both human and mosquito population.Fig. 1

According to the assumptions and from the flow diagram, the dynamics of the Zika virus can be represented by the following system of non linear differential equations:$$\left. \begin{array}{l}
{\frac{dS_{h}}{dt} = \pi - \left( {\lambda_{1} + \lambda_{2}} \right)S_{h} - \left( {\mu + a} \right)S_{h}} \\
{\frac{dE_{h}}{dt} = \left( {\lambda_{1} + \lambda_{2}} \right)S_{h} - \left( {\sigma + \mu} \right)E_{h}} \\
{\frac{dI_{h}}{dt} = \sigma E_{h} - \left( {\gamma + \mu} \right)I_{h}} \\
{\frac{dR_{h}}{dt} = \gamma I_{h} - \mu R_{h} + aS_{h}} \\
{\frac{dS_{v}}{dt} = \pi_{1} - \lambda_{v}S_{v} - \left( {\mu_{1} + b} \right)S_{v}} \\
{\frac{dE_{v}}{dt} = \lambda_{v}S_{v} - \left( {\sigma_{1} + \mu_{1} + b} \right)E_{v}} \\
{\frac{dI_{v}}{dt} = \sigma_{1}E_{v} - \left( {\mu_{1} + b} \right)I_{v}} \\
\end{array} \right\}$$

The state variables and parameters used in the zika transmission model are summarised in [Table 1](#tbl1){ref-type="table"}.Table 1Description of state variables and parametersTable 1*State variablesDescription*$N_{h}$*Total human population*$S_{h}$*Susceptible human population*$E_{h}$*Exposed human population*$I_{h}$*Infected human population*$R_{h}$*Recovered human population*$N_{v}$*Total vector population*$S_{v}$*Susceptible vector population*$E_{v}$*Exposed vector population*$I_{v}$*Infected vector populationParametersDescription*$\pi$,$\pi_{1}$*Recruitment rate of human and mosquito respectively*$\mu$, $\mu_{1}$*Natural death rate of human and mosquito respectively*$b_{2}$*Mosquito biting rate*$\alpha_{1}$*Transmission probability per biting of -Susceptible humans with infected mosquito*$\alpha_{3}$*Transmission probability per biting of Susceptible mosquito with infected humans*.$c$*Sexual contact rate between a susceptible human to an infected human*$\alpha_{2}$*Transmission probability per sexual contact- among a susceptible and infected human*$\sigma$*Progression rate from exposed to infected human*$\gamma$*Recovery rate of infected human*$a$*Rate of awareness in host population*$\sigma_{1}$*Progression rate from exposed to infected mosquito*$b$*Constant rate of effective mosquito control*

2.1. Positivity and boundedness of the solutions {#sec2.1}
------------------------------------------------

The considered model will be biologically meaningful when all the variables are non-negative for $t \geq 0$. In other words the solution with positive initial conditions will remain positive for all time, which we shall establish in the following Lemma.Lemma 1*Let* $G\left( t \right) = \left( {S_{h},E_{h},I_{h},R_{h},S_{v},E_{v},I_{v}} \right)$*with the initial condition* $G\left( 0 \right) \geq 0$.*Then the solutions* $G\left( t \right)$ *of the model* (1) *is non negative for all* $t \geq 0$. *Also* $\lim\limits_{t\rightarrow\infty}\sup N_{h}\left( t \right) = \frac{\pi}{\mu}$*and*$\lim\limits_{t\rightarrow\infty}\sup N_{v}\left( t \right) = \frac{\pi_{1}}{\mu_{1} + b}$*hold*.***Proof***: *Since* $\lambda_{1}$*is a function of* $I_{v},\ N_{h}$*and* $\lambda_{2}$*is a function of* $I_{h},N_{h}$ *and for* $T = \sup\left\{ {t > 0:G\left( t \right) > 0} \right\}$ *the first equation of the model* (1) *can be explicitly written as*:$$\frac{dS_{h}}{dt} = \pi - \lambda_{1}\left( {I_{v},N_{h}} \right)S_{h}\left( t \right) - \lambda_{2}\left( {I_{h},N_{h}} \right)S_{h}\left( t \right) - \left( {\mu + a} \right)S_{h}\left( t \right)$$*Integrating the above equation in the range* \[0, *T*\] *we get*,$$\begin{array}{l}
{\frac{d}{dt}\left\{ {S_{h}\left( t \right)\left\lbrack {\exp\left( {\int\limits_{0}^{T}{\left\lbrack {\lambda_{1}\left( {I_{v}\left( \eta \right),N_{h}\left( \eta \right)} \right) + \lambda_{2}\left( {I_{h}\left( \eta \right),N_{h}\left( \eta \right)} \right)} \right\rbrack d\eta}} \right) + \left( {\mu + a} \right)T} \right\rbrack} \right\}} \\
{= \pi\ \exp\left( {\int\limits_{0}^{T}{\left\lbrack {\lambda_{1}\left( {I_{v}\left( \eta \right),N_{h}\left( \eta \right)} \right) + \lambda_{2}\left( {I_{h}\left( \eta \right),N_{h}\left( \eta \right)} \right)} \right\rbrack d\eta + \left( {\mu + a} \right)T}} \right)} \\
\end{array}$$*which gives*$$\begin{array}{l}
{S_{h}\left( T \right)\exp\left\lbrack \left( {\int\limits_{0}^{T}{\left( {\lambda_{1}\left( {I_{v}\left( \eta \right),N_{h}\left( \eta \right)} \right) + \lambda_{2}\left( {I_{h}\left( \eta \right),N_{h}\left( \eta \right)} \right)} \right)d\eta + \left( {\mu + a} \right)T}} \right) \right\rbrack - S_{h}\left( 0 \right)} \\
{= {\int\limits_{0}^{T}{\pi\ \exp\left( {\int\limits_{0}^{y}{\left\lbrack {\lambda_{1}\left( {I_{v}\left( \eta \right),N_{h}\left( \eta \right)} \right) + \lambda_{2}\left( {I_{h}\left( \eta \right),N_{h}\left( \eta \right)} \right)} \right\rbrack d\eta + \left( {\mu + a} \right)y}} \right)dy}}} \\
\end{array}$$*or*$$S_{h}\left( T \right) = S_{h}\left( 0 \right)\exp\left\lbrack {- \left( {\int\limits_{0}^{T}{\left( {\lambda_{1}\left( {I_{v}\left( \eta \right),N_{h}\left( \eta \right)} \right) + \lambda_{2}\left( {I_{h}\left( \eta \right),N_{h}\left( \eta \right)} \right)} \right)d\eta + \left( {\mu + a} \right)T}} \right)} \right\rbrack$$$$+ \exp\left\lbrack {- \left( {\int\limits_{0}^{T}{\left( {\lambda_{1}\left( {I_{v}\left( \eta \right),N_{h}\left( \eta \right)} \right) + \lambda_{2}\left( {I_{h}\left( \eta \right),N_{h}\left( \eta \right)} \right)} \right)d\eta + \left( {\mu + a} \right)T}} \right)} \right\rbrack$$$$\times {\int\limits_{0}^{T}{\pi\ \exp\left( {\int\limits_{0}^{y}{\left\lbrack {\lambda_{1}\left( {I_{v}\left( \eta \right),N_{h}\left( \eta \right)} \right) + \lambda_{2}\left( {I_{h}\left( \eta \right),N_{h}\left( \eta \right)} \right)} \right\rbrack d\eta + \left( {\mu + a} \right)y}} \right)dy}} > 0$$*Similarly it can be shown that* $E_{h}\left( T \right),I_{h}\left( T \right),R_{h}\left( T \right),S_{v}\left( T \right),E_{v}\left( T \right)$*and* $I_{v}\left( T \right)$*all are positive for all* $T > 0$ *thus* $G > 0$*for all* $t > 0$. *Hence the first part of the Lemma is proved*.

*For the next part of the Lemma it should be noted that* $0 < S_{h}\left( t \right),E_{h}\left( t \right),I_{h}\left( t \right),R_{h}\left( t \right) \leq N_{h}\left( t \right),0 < S_{v}\left( t \right),E_{v}\left( t \right),I_{v}\left( t \right) \leq N_{v}\left( t \right).$

*Adding first four component equations of the model* (1) *we have*$$\frac{dN_{h}}{dt} = \pi - \mu N_{h}$$

*Similarly adding last three equations of the model* (1) *we have*$$\frac{dN_{v}}{dt} = \pi_{1} - \left( {\mu_{1} + b} \right)N_{v}$$

*Integrating and taking limsup and liminf for* $\left. t\rightarrow\infty \right.$*in the above two equations we get*, $\frac{\pi}{\mu} \leq \lim\limits_{t\rightarrow\infty}\inf N_{h}\left( t \right) \leq \lim\limits_{t\rightarrow\infty}\sup N_{h}\left( t \right) \leq \frac{\pi}{\mu}$ *and* $\frac{\pi_{1}}{\mu_{1} + b} \leq \lim\limits_{t\rightarrow\infty}\ \ \inf N_{v}\left( t \right) \leq \lim\limits_{t\rightarrow\infty}\ \ \sup N_{v}\left( t \right) \leq \frac{\pi_{1}}{\mu_{1} + b}$, *which implies* $\lim\limits_{t\rightarrow\infty}\sup N_{h}\left( t \right) = \frac{\pi}{\mu},$ *and* $\lim\limits_{t\rightarrow\infty}\ \ \sup N_{v}\left( t \right) = \frac{\pi_{1}}{\mu_{1} + b}$.

*We shall now analyze our proposed zika virus transmission model* (1) *in the following biologically feasible closed region* $\Omega$*which is defined below*:$$\Omega = \left\{ {\left( {S_{h},E_{h},I_{h},R_{h},S_{v},E_{v},I_{v}} \right) \in \Re_{+}^{7}:S_{h} + E_{h} + I_{h} + R_{h} \leq \frac{\pi}{\mu},S_{v} + E_{v} + I_{v} \leq \frac{\pi_{1}}{\mu_{1} + b}} \right\}$$

*In the next Lemma we shall establish the closed region*$\Omega$ *as a positively invariant set*.Lemma 2*The closed region* $\Omega$ *defined above is a positively invariant set for the model* (1) *with non- negative initial condition in*$\Re^{7}$.***Proof***: *Here* $N_{h} = S_{h} + E_{h} + I_{h} + R_{h}$, *so the rate of change of the total human population*$N_{h}$ *isobtained from equation* [(2)](#fd2){ref-type="disp-formula"} *in the form*.$\frac{dN_{h}}{dt} = \pi - \mu N_{h}$ *Similarly total vector population is* $N_{v} = S_{v} + E_{v} + I_{v}$, *and hence the rate of change of the total mosquito is obtained from* (3), *as*$$\frac{dN_{v}}{dt} = \pi_{1} - \left( {\mu_{1} + b} \right)N_{v}$$*Using a standard comparison theorem from* [@bib24] *it can be shown that*$N_{h}\left( t \right) \leq N_{h}\left( 0 \right)e^{- \mu t} + \frac{\pi}{\mu}\left( {1 - e^{- \mu t}} \right)$ and $N_{v}\left( t \right) \leq N_{v}\left( 0 \right)e^{- {({\mu_{1} + b})}t} + \frac{\pi_{1}}{\mu_{1} + b}\left( {1 - e^{- {({\mu_{1} + b})}t}} \right)$.*This follows*$N_{h}\left( t \right) \leq \frac{\pi}{\mu}$*and* $N_{v}\left( t \right) \leq \frac{\pi_{1}}{\mu_{1} + b}$*if* $N_{h}\left( 0 \right) \leq \frac{\pi}{\mu}$ *and*$N_{v}\left( 0 \right) \leq \frac{\pi_{1}}{\mu_{1} + b}$ *respectively*.*Thus the closed region* $\Omega$ *is positively invariant*.*Again if* $N_{h}\left( 0 \right) > \frac{\pi}{\mu}$*and* $N_{v}\left( 0 \right) > \frac{\pi_{1}}{\mu_{1} + b}$*then the solution contained in* $\Omega$ *or* $N_{h}\left( t \right)$ *approach to* $\frac{\pi}{\mu}$*and* $N_{v}\left( t \right)$ *approach to*$\frac{\pi_{1}}{\mu_{1} + b}$ *and then the infected classes* $E_{h},I_{h},E_{v}$ *and* $I_{v}$ *approach to zero*, *so* $\Omega$ *is attracting set that is all solutions in* $\Re_{+}^{7}$ *eventually enters in* $\Omega$. *So*, *biologically and mathematically the model is well posed in the invariant set* $\Omega$ ([@bib20]). *Hence*, *it is sufficient to consider the dynamics of the transmission of zika virus model* (1) *in the invariant set* $\Omega$.

3. Steady state analysis {#sec3}
========================

In this section we shall carry out qualitative analysis of the model (1) to investigate existence and stability of the steady states.

3.1. Disease free equilibrium and basic reproduction numbers {#sec3.1}
------------------------------------------------------------

The disease free equilibrium (DFE) of the model (1) is obtained by using $E_{h} = I_{h} = E_{v} = I_{v} = 0$ in the steady state conditions.

Thus the disease free equilibrium point $E_{0}$ of the model (1) is given by $E_{0}\left( {S_{h}^{0},E_{h}^{0},I_{h}^{0},R_{h}^{0},S_{v}^{0},E_{v}^{0},I_{v}^{0}} \right) = \left( {\frac{\pi}{\mu + a},0,0,\frac{a\pi}{\mu\left( {\mu + a} \right)},\frac{\pi_{1}}{\mu_{1} + b},0,0} \right)$.

In order to calculate the basic reproduction number we use the next generation operator method on the model (1). Consider the infected compartments $\left( {E_{h},I_{h},E_{v},I_{v}} \right)$ at the disease free equilibrium (DFE) and applying Vanden Diressche and Watmaugh ([@bib37]) technique, the Jacobian matrices $F$and $V$ (for the new infection terms and the remaining transfer terms respectively) are given by.

$F = \begin{pmatrix}
0 & {\lambda_{2}^{0}S_{h}^{0}} & 0 & {\lambda_{1}^{0}S_{h}^{0}} \\
0 & 0 & 0 & 0 \\
0 & {\lambda_{v}^{0}S_{v}^{0}} & 0 & 0 \\
0 & 0 & 0 & 0 \\
\end{pmatrix}$$,V = \begin{pmatrix}
k_{1} & 0 & 0 & 0 \\
{- \sigma} & k_{2} & 0 & 0 \\
0 & 0 & k_{3} & 0 \\
0 & 0 & {- \sigma_{1}} & k_{4} \\
\end{pmatrix}$, so that ${FV^{- 1} = \frac{1}{k_{1}k_{2}k_{3}k_{4}}\begin{pmatrix}
a_{1} & a_{2} & a_{3} & a_{4} \\
0 & 0 & 0 & 0 \\
a_{5} & a_{6} & 0 & 0 \\
0 & 0 & 0 & 0 \\
\end{pmatrix}}\ \ $ $\text{where},k_{1} = \sigma + \mu,k_{2} = \gamma + \mu,k_{3} = \sigma_{1} + \mu_{1} + b,k_{4} = \mu_{1} + b,\ \lambda_{1}^{0} = \frac{b_{2}\alpha_{1}}{N_{h}^{0}},\ \lambda_{2}^{0} = \frac{c\alpha_{2}}{N_{h}^{0}},\ \lambda_{v}^{0} = \frac{b_{2}\alpha_{3}}{N_{h}^{0}},a_{1} = \lambda_{2}^{0}S_{h}^{0}\sigma k_{3}k_{4}$$a_{1} = \lambda_{2}^{0}S_{h}^{0}\sigma k_{3}k_{4},a_{2} = \lambda_{2}^{0}S_{h}^{0}k_{1}k_{3}k_{4},a_{3} = \lambda_{1}^{0}S_{h}^{0}k_{1}k_{2}\sigma_{1},a_{4} = \lambda_{1}^{0}S_{h}^{0}k_{1}k_{2}k_{3},a_{5} = \lambda_{v}^{0}S_{v}^{0}\sigma k_{3}k_{4},a_{6} = \lambda_{v}^{0}S_{v}^{0}k_{1}k_{3}k_{4}.$ Now, the basic reproduction number $R_{0}$ is obtained as the spectral radius $\rho\left( {FV^{- 1}} \right)$ ([@bib37]) that is the dominant Eigen value of the matrix $FV^{- 1}$.

The characteristic polynomial of the matrix $FV^{- 1}$ is $\lambda^{2}\left( {\lambda^{2} - l\lambda - m} \right)$ where $l = a_{1}/D,m = a_{3}a_{5}/D^{2},D = k_{1}k_{2}k_{3}k_{4}$and the quadratic polynomial of the above characteristic polynomial is $g\left( \lambda \right) = \left( {\lambda^{2} - l\lambda - m} \right)$ with $l > 0,m > 0$.So $g\left( \lambda \right) = 0$ gives a unique positive root, which provides the basic reproduction number $R_{0}$ given below:

$R_{0} = \rho\left( {FV^{- 1}} \right) = \frac{1}{2k_{1}k_{2}k_{3}k_{4}}\left\{ {\lambda_{2}^{0}S_{h}^{0}\sigma k_{3}k_{4} + \left( {\left( {\lambda_{2}^{0}S_{h}^{0}\sigma k_{3}k_{4}} \right)^{2} + 4\lambda_{1}^{0}\lambda_{v}^{0}S_{h}^{0}S_{v}^{0}\sigma\sigma_{1}k_{1}k_{2}k_{3}k_{4}} \right)^{\frac{1}{2}}} \right\}$.

Again $g\left( 0 \right) = - m < 0$ and$g\left( 1 \right) = 1 - \left( {l + m} \right)$. Define $R_{o}^{\prime} = l + m$ that is $R_{0}^{\prime} = \frac{\sigma}{k_{1}k_{2}k_{3}k_{4}}\left( {\lambda_{2}^{0}S_{h}^{0}k_{3}k_{4} + \lambda_{1}^{0}S_{h}^{0}\sigma_{1}\lambda_{v}^{0}S_{V}^{0}} \right) = R_{0S}^{\prime} + R_{0V}^{\prime}$ where $R_{0S}^{\prime} = \frac{\lambda_{2}^{0}S_{h}^{0}k_{3}k_{4}\sigma}{k_{1}k_{2}k_{3}k_{4}}$ is the contribution from sexual transmission and $R_{0V}^{\prime} = \frac{\lambda_{1}^{0}S_{h}^{0}\sigma_{1}\lambda_{V}^{0}S_{V}^{0}\sigma}{k_{1}k_{2}k_{3}k_{4}}$ is the contribution from mosquito (vector) transmission. Again from the relation $g\left( 1 \right) = 1 - R_{0}^{\prime}$ we have the following three observation:(i)when $R_{0}^{\prime} = 1$ then $g\left( 1 \right) = 0$ thus the positive root of the equation $g\left( \lambda \right) = 0$ is one *i.e* $R_{0} = 1$ (ii) when $R_{0}^{\prime} < 1$ then $g\left( 1 \right) > 0$ so the positive root of the equation $g\left( \lambda \right) = 0$ lies between zero and one as $g\left( 0 \right) < 0$ thus $R_{0} < 1$.(iii) when $R_{0}^{\prime} > 1$ then $g\left( 1 \right) < 0$ again $g\left( 0 \right) < 0$ so positive root of $g\left( \lambda \right) = 0$ greater than one that is $R_{0} > 1$. Thus from the above three observation one can conclude that $R_{0}^{\prime} = 1\left( {< 1, > 1} \right)$ if and only if $R_{0} = 1\left( {< 1, > 1} \right)$. Since two threshold numbers $R_{0}$ and $R_{0}^{\prime}$ are equivalent so we use only$R_{0}^{\prime}$ in the next part of the paper.

### 3.2.1. Local stability of the disease free equilibrium {#sec3.1.1}

Lemma 3*The disease free equilibrium* (*DFE*) $E_{0}$*is locally asymptotically stable for* $R_{0}^{\prime} < 1$ *and unstable for* $R_{0}^{\prime} > 1$ *where* $R_{0}^{\prime}$ *is defined in the text*.***Proof***. *The variational matrix of the model* (1) *at the disease free equilibrium* $E_{0}\left( {S_{h}^{0},E_{h}^{0},I_{h}^{0},R_{h}^{0},S_{v}^{0},E_{v}^{0},I_{v}^{0}} \right)$ *is given by*$$J\left( E_{0} \right) = \begin{pmatrix}
{- \left( {\mu + a} \right)} & 0 & {- \lambda_{2}^{0}S_{h}^{0}} & 0 & 0 & 0 & {- \lambda_{1}^{0}S_{h}^{0}} \\
0 & {- k_{1}} & {\lambda_{2}^{0}S_{h}^{0}} & 0 & 0 & 0 & {\lambda_{1}^{0}S_{h}^{0}} \\
0 & \sigma & {- k_{2}} & 0 & 0 & 0 & 0 \\
a & 0 & \gamma & {- \mu} & 0 & 0 & 0 \\
0 & 0 & {- \lambda_{v}^{0}S_{v}^{0}} & 0 & {- k_{4}} & 0 & 0 \\
0 & 0 & {\lambda_{v}^{0}S_{v}^{0}} & 0 & 0 & {- k_{3}} & 0 \\
0 & 0 & 0 & 0 & 0 & \sigma_{1} & {- k_{4}} \\
\end{pmatrix}$$*The characteristic roots corresponding to matrix* $J\left( E_{0} \right)$ *are*$- \left( {\mu + a} \right), - \mu, - k_{4}$ *and the remaining four roots are roots of the following equation*:(4)$$x^{4} + m_{1}x^{3} + m_{2}x^{2} + m_{3}x + m_{4} = 0$$$$\begin{array}{l}
{\text{where}\ m_{1} = k_{1} + k_{2} + k_{3} + k_{4},m_{2} = k_{1}k_{2} + k_{1}k_{3} + k_{1}k_{4} + k_{2}k_{3} + k_{2}k_{4} + k_{3}k_{4} - \sigma c\alpha_{2},} \\
{m_{3} = k_{1}k_{3}k_{4} + k_{2}k_{3}k_{4} + \left( {k_{3} + k_{4}} \right)\left( {k_{1}k_{2} - \sigma c\alpha_{2}} \right),m_{4} = k_{1}k_{2}k_{3}k_{4}\left( {1 - R_{0}^{\prime}} \right)} \\
\end{array}$$*Now by the Routh-Hurtwiz criteria the eigen values of the block matrix* $B$ *will be negative or have negative real part if* $m_{i} > 0,\ \ for\ \ i = 1,2,3,4$*and* $m_{1}m_{2}m_{3} > m_{1}^{2}m_{4} + m_{3}^{2}$. *All these conditions will be satisfied if* $R_{0}^{\prime} < 1$. *Thus by Routh-Hurtwiz criteria the disease free equilibrium* (*DFE*) *is locally asymptotically stable if* $R_{0}^{\prime} < 1$. *Thus the disease free equilibrium* (*DFE*) $E_{0}$*is locally asymptotically stable for* $R_{0}^{\prime} < 1$ *otherwise it is unstable*.

*Using the Lemma-*3 *we can say that zika virus can be eliminated from the population when*$R_{0}^{\prime}$ *can be brought to a value less than unity*. *It is clear from the expression of* $R_{0}$ *that with the increase of both the rate of awareness* ($a$) *in host population and the rate of effective mosquito control* ($b$) $R_{0}$*decreases*. *Thus the factors*$a$ *and*$b$ *help us to keep the value of* $R_{0}^{\prime}$ *below unity and increase the range of stability of the disease free equilibrium*. *Thus we can speak that awareness in host population and vector control helps the society to eliminate zika virus from human population*.

### 3.2.2. Global asymptotic stability of the disease free equilibrium {#sec3.1.2}

In this section we have studied the global asymptotic stability of the disease free equilibrium (DFE) to ensure that the elimination of zika virus i.e. elimination of disease is independent of the initial sizes of the subpopulations of the model. For this purpose we consider the feasible region $\Omega_{1} = \left\{ {X \in \Omega:S_{h} \leq S\mspace{2mu}_{h}^{0},S_{v} \leq S_{v}^{0}} \right\}$ where $X = \left( {S_{h},E_{h},I_{h},R_{h},S_{v},E_{v},I_{v}} \right)$ and to establish the invariance of the region we shall establish the following Lemma.Lemma 4*The region* $\Omega_{1}$ *is a positively invariant for the model* (1).***Proof***: *From the first equation of the model* (1) *we have*$$\frac{dS_{h}}{dt}\left( t \right) = \pi - \left( {\lambda_{1} + \lambda_{2}} \right)S_{h}\left( t \right) - \left( {\mu + a} \right)S_{h}\left( t \right) \leq \pi - \left( {\mu + a} \right)S_{h}\left( t \right) = \left( {\mu + a} \right)\left( {\frac{\pi}{\mu + a} - S_{h}\left( t \right)} \right)$$$= \left( {\mu + a} \right)\left( {S_{h}^{0} - S_{h}\left( t \right)} \right)$ *as* $S_{h}^{0} = \frac{\pi}{\mu + a}$ *which gives* $S_{h}\left( t \right) \leq S_{h}^{0} - \left\lbrack {S_{h}^{0} - S_{h}\left( 0 \right)} \right\rbrack e^{- {({\mu + a})}t}$. *Thus if* $S_{h}\left( 0 \right) \leq S_{h}^{0}$*for all* $t \geq 0$ *then*$S_{h}\left( t \right) \leq S_{h}^{0}$ *for all* $t \geq 0\ .$*Again from the fifth equation of the model* (1) *we have*$$\frac{dS_{v}}{dt}\left( t \right) = \pi_{1} - \lambda_{v}S_{v} - \left( {\mu_{1} + b} \right)S_{v}\left( t \right) \leq \pi_{1} - \left( {\mu_{1} + b} \right)S_{v}\left( t \right)$$$$= \left( {\mu_{1} + b} \right)\left\{ {\frac{\pi_{1}}{\mu_{1} + b} - S_{v}\left( t \right)} \right\} = \left( {\mu_{1} + b} \right)\left( {S_{v}^{0} - S_{v}\left( t \right)} \right).$$*Which gives* $S_{v}\left( t \right) \leq S_{v}^{0} - \left( {S_{v}^{0} - S_{v}\left( 0 \right)} \right)e^{- {({\mu_{1} + b})}t}$. *Thus if* $S_{v}\left( 0 \right) \leq S_{v}^{0}$ *for all* $t \geq 0$ *then* $S_{v}\left( t \right) \leq S_{v}^{0}$ *for all* $t \geq 0$.*Summing above two we have the region* $\Omega_{1}$ *is positively invariant and attracts all solutions in*$\Re^{7}$ *for the model* (1). *In the next theorem we have studied the global asymptotic stability of* $E_{0}$.Theorem 1*The disease free equilibrium* $E_{0}$ *of the model* (1) *is globally asymptotically stable* (*GAS*) *in* $\Omega_{1}$*whenever* $R_{0}^{\prime} \leq 1$.*Proof*: *Let* $X_{1} = \left( {S_{h},R_{h},S_{v}} \right)$ *and* $X_{2} = \left( {E_{h},I_{h},E_{v},I_{v}} \right)$ *and grouping the model* (1) *into*$$\begin{array}{l}
{\frac{dX_{1}}{dt} = F\left( {X_{1},0} \right)} \\
{\frac{dX_{2}}{dt} = G\left( {X_{1},X_{2}} \right)} \\
\end{array}$$*where* $F\left( {X_{1},0} \right)$*is obtained from the right hand side of first*, *fourth and fifth equations of the model* (1) *with* $E_{h} = I_{h} = E_{v} = I_{v} = 0$*and* $G\left( {X_{1},X_{2}} \right)$ *is obtained from the right hand side of second*, *third*, *sixth and seventh equations of the model* (1).*Now considering the reduced model*:$$\left. \begin{array}{l}
{\frac{dS_{h}}{dt} = \pi - \left( {\mu + a} \right)S_{h}} \\
{\frac{dR_{h}}{dt} = - \mu R_{h} + aS_{h}} \\
{\frac{dS_{v}}{dt} = \pi_{1} - \left( {\mu_{1} + b} \right)S_{v}} \\
\end{array} \right\}$$*Let* $X_{1}^{0} = \left( {S_{h}^{0},R_{h}^{0},S_{v}^{0}} \right) = \left( {\frac{\pi}{\mu + a},\frac{a\pi}{\mu\left( {\mu + a} \right)},\frac{\pi_{1}}{\mu_{1} + b}} \right)$ *be the equilibrium of the reduced model* (5). *Now we shall show that* $X_{1}^{0}$ *is a globally stable equilibrium in* $\Omega_{1}$ .*To prove this we solve the* equations [(5)](#fd5){ref-type="disp-formula"} *which gives*:$S_{h}\left( t \right) = \frac{\pi}{\mu + a} + \left\lbrack {S_{h}\left( 0 \right) - \frac{\pi}{\mu + a}} \right\rbrack e^{- {({\mu + a})}t},S_{v}\left( t \right) = \frac{\pi_{1}}{\mu_{1} + b} + \left\lbrack {S_{v}\left( 0 \right) - \frac{\pi_{1}}{\mu_{1} + b}} \right\rbrack e^{- {({\mu_{1} + b})}}$ *and* $R_{h}\left( t \right) = \frac{a\pi}{\mu\left( {\mu + a} \right)} - \left( {S_{h}\left( 0 \right) - \frac{\pi}{\mu + a}} \right)e^{- {({\mu + a})}t} + \left( {R_{h}\left( 0 \right) + S_{h}\left( 0 \right) - \frac{\pi}{\mu + a} - \frac{a\pi}{\mu\left( {\mu + a} \right)}} \right)e^{- \mu t}.$*Thus* $\left. S_{h}\rightarrow\frac{\pi}{\mu + a},R_{h}\rightarrow\frac{a\pi}{\mu\left( {\mu + a} \right)},S_{v}\rightarrow\frac{\pi_{1}}{\mu_{1} + b} \right.$ *as* $\left. t\rightarrow\infty \right.$.*This asymptotic nature is independent of initial conditions in* $\Omega_{1}$. *Hence the convergence of solutions of* (2) *is global in* $\Omega_{1}$. *Next we require* $G\left( {X_{1},X_{2}} \right)$ *is to satisfy the following two conditions given in Castill-Chavez et al* ([@bib6]), *namely*1. $G\left( {X_{1},\overset{\rightarrow}{0}} \right) = \overset{\rightarrow}{0}$ *and* 2 . $\widehat{G}\left( {X_{1},X_{2}} \right) = D_{X_{2}}G\left( {X_{1}^{0},\overset{\rightarrow}{0}} \right)X_{2} - G\left( {X_{1},X_{2}} \right),\widehat{G}\left( {X_{1},X_{2}} \right) \geq 0$*Where* $\left( {X_{1}^{0},\overset{\rightarrow}{0}} \right) = \left( {\frac{\pi}{\mu + a},0,0,\frac{a\pi}{\mu\left( {\mu + a} \right)},\frac{\pi_{1}}{\pi_{1} + b},0,0} \right)$ *and* $D_{X_{2}}G\left( {X_{1}^{0},\overset{\rightarrow}{0}} \right) = \begin{pmatrix}
{- k_{1}} & {\lambda_{2}^{0}S_{h}^{0}} & 0 & {\lambda_{1}^{0}S_{h}^{0}} \\
\sigma & {- k_{2}} & 0 & 0 \\
0 & {\lambda_{v}^{0}S_{v}^{0}} & {- k_{3}} & 0 \\
0 & 0 & \sigma_{1} & {- k_{4}} \\
\end{pmatrix}$ *is the Jacobian of* $G\left( {X_{1},X_{2}} \right)$ *with respect to* $\left( {E_{h},I_{h},E_{v},I_{v}} \right)$ *is calculated at* $\left( {X_{1}^{0},\overset{\rightarrow}{0}} \right)$.*It is an M-matrix that is off diagonal elements of the matrix are non-negative*. *The relation*$\widehat{G}\left( {X_{1},X_{2}} \right) = D_{X_{2}}G\left( {X_{1}^{0},\overset{\rightarrow}{0}} \right)X_{2} - G\left( {X_{1},X_{2}} \right)$ *gives* ${\widehat{G}\left( {X_{1},X_{2}} \right) = \begin{pmatrix}
{\widehat{G}}_{1} \\
0 \\
{\widehat{G}}_{3} \\
0 \\
\end{pmatrix}}\text{with}\ {\widehat{G}}_{1} = c\alpha_{2}\frac{S_{h}^{0}}{N_{h}^{0}}\left( {1 - \frac{N_{h}^{0}}{S_{h}^{0}}\frac{S_{h}}{N_{h}}} \right)I_{h} + b_{2}\alpha_{1}\frac{S_{h}^{0}}{N_{h}^{0}}\left( {1 - \frac{N_{h}^{0}}{S_{h}^{0}}\frac{S_{h}}{N_{h}}} \right)I_{v}.{\widehat{G}}_{3} = b_{2}\alpha_{3}\frac{S_{v}^{0}}{N_{h}^{0}}\left( {1 - \frac{N_{h}^{0}}{S_{v}^{0}}\frac{S_{v}}{N_{h}}} \right)I_{h}.$*In the region* $\Omega_{1},S_{h} \leq S_{h}^{0},S_{v} \leq S_{v}^{0}$ *and hence we get* $N_{h} \leq N_{h}^{0}$. *Thus*, *if the human population is at equilibrium level then we have* $\left( {1 - \frac{N_{h}^{0}}{S_{h}^{0}}\frac{S_{h}}{N_{h}}} \right) > 0,\left( {1 - \frac{N_{h}^{0}}{S_{v}^{0}}\frac{S_{v}}{N_{h}}} \right) > 0$*therefore* $\widehat{G}\left( {X_{1},X_{2}} \right) \geq \overset{\rightarrow}{0}$. *So by the theorem in Castilo-Chavez et al* ([@bib6]) *the disease free equilibrium is globally asymptotically stable as the human population is constant in the absence of disease induced death*. *The biological significance of the above theorem is that the zika virus can be eliminated from the population if* $R_{0}$ *can be brought down to a value less than or equal to unity what so ever the size of the initial subpopulation in each class*.

3.3. Existence and stability of endemic equilibrium point {#sec3.2}
---------------------------------------------------------

In this part we shall find conditions for the existence and stability of endemic equilibrium for the model (1). Let $E_{1}\left( {{S^{\ast}}_{h},{E^{\ast}}_{h},{I^{\ast}}_{h},{R^{\ast}}_{h},{S^{\ast}}_{v},{E^{\ast}}_{v},{I^{\ast}}_{v}} \right)$ be an arbitrary endemic equilibrium of the model (1) which have been obtained from the steady states of the model, where the components of $E_{1}$ are given below:$$\begin{array}{l}
{S_{h}^{\ast} = \frac{\pi}{\lambda_{h}^{\ast} + \mu + a},E_{h}^{\ast} = \frac{\pi\lambda_{h}^{\ast}}{k_{1}\left( {\lambda_{h}^{\ast} + \mu + a} \right)},I_{h}^{\ast} = \frac{\pi\sigma\lambda_{h}^{\ast}}{k_{1}k_{2}\left( {\lambda_{h}^{\ast} + \mu + a} \right)},R_{h}^{\ast} = \frac{\pi\left( {\gamma\sigma\lambda_{h}^{\ast} + ak_{1}k_{2}} \right)}{\mu k_{1}k_{2}\left( {\lambda_{h}^{\ast} + \mu + a} \right)}} \\
{S_{v}^{\ast} = \frac{\pi_{1}}{\lambda_{v}^{\ast} + \mu_{1} + b},E_{v}^{\ast} = \frac{\pi_{1}\lambda_{v}^{\ast}}{k_{3}\left( {\lambda_{v}^{\ast} + \mu_{1} + b} \right)},I_{v}^{\ast} = \frac{\pi_{1}\sigma_{1}\lambda_{v}^{\ast}}{k_{3}k_{4}\left( {\lambda_{v}^{\ast} + \mu_{1} + b} \right)}} \\
\end{array}$$with$$\lambda_{v}^{\ast} = \frac{b_{2}\alpha_{3}I_{h}^{\ast}}{N_{h}^{\ast}} = \frac{b_{2}\alpha_{3}\mu\sigma\lambda_{h}^{\ast}}{k_{1}k_{2}\left( {\lambda_{h}^{\ast} + \mu + a} \right)}$$$$\lambda_{h}^{\ast} = \frac{b_{2}\alpha_{1}I_{v}^{\ast}}{N_{h}^{\ast}} + \frac{c\alpha_{2}I_{h}^{\ast}}{N_{h}^{\ast}} = \frac{\mu}{\pi}\left\lbrack {\frac{b_{2}\alpha_{1}\pi_{1}\sigma_{1}\lambda_{v}^{\ast}}{k_{3}k_{4}\left( {\lambda_{v}^{\ast} + \mu_{1} + b} \right)} + \frac{c\alpha_{2}\pi\sigma\lambda_{h}^{\ast}}{k_{1}k_{2}\left( {\lambda_{h}^{\ast} + \mu + a} \right)}} \right\rbrack$$

The expressions of $\lambda_{v}^{\ast},\lambda_{h}^{\ast}$ represent the forces of infection of mosquitoes and human at steady state. Substituting the value of $\lambda_{v}^{\ast}$ from (6) in (7) and simplifying we get the quadratic equation satisfied by $\lambda_{h}^{\ast}$ in the form:$$c_{0}{\lambda_{h}^{\ast}}^{2} + c_{1}\lambda_{h}^{\ast} + c_{2} = 0$$where $\begin{array}{l}
{c_{0} = \pi k_{1}k_{2}k_{3}k_{4}\left\{ {b_{2}\alpha_{3}\mu\sigma + k_{1}k_{2}\left( {\mu_{1} + b} \right)} \right\} > 0,c_{2} = \pi{k_{1}}^{2}{k_{2}}^{2}k_{3}k_{4}\left( {\mu + a} \right)^{2}\left( {\mu_{1} + b} \right)\left( {1 - R_{0}^{\prime}} \right)} \\
{c_{1} = \pi k_{1}k_{2}k_{3}k_{4}\left( {\mu + a} \right)\left\lbrack {b_{2}\alpha_{3}\mu\sigma + 2k_{1}k_{2}\left( {\mu_{1} + b} \right)} \right\rbrack - \mu\sigma\left\lbrack {k_{1}k_{2}{b_{2}}^{2}\alpha_{1}\alpha_{3}\pi_{1}\sigma_{1}\mu + \left\{ {b_{2}\alpha_{3}\mu\sigma + k_{1}k_{2}\left( {\mu_{1} + b} \right)} \right\} c\alpha_{2}\pi k_{3}k_{4}} \right\rbrack} \\
\end{array}$ The endemic equilibrium of the model (1) can be obtained by solving the quadratic equation [(8)](#fd8){ref-type="disp-formula"} for $\lambda_{h}^{\ast}$ and substituting into (l). From the expression of $\lambda_{h}^{\ast}$ it is clear that $c_{0}$ is always positive and $c_{2}$ is positive if $R_{0}^{\prime} < 1$. Since equation [(8)](#fd8){ref-type="disp-formula"} is a second degree equation in $\lambda_{h}^{\ast}$, depending on values of $\lambda_{h}^{\ast}$ the number of endemic equilibrium point will be generated. Thus from the above discussions we can summarize the following theorem:Theorem 2*The model* (1) *has*(a)*An endemic equilibrium if* $\left. c_{2} < 0\Leftrightarrow R_{0}^{\prime} > 1 \right.$ *or* $c_{1} < 0,c_{2} = 0$ *that is* $R_{0}^{\prime} = 1$**.**(b)*A unique coincident endemic equilibrium if c*~1~*\<*0 *and* ${c_{1}}^{2} - 4c_{0}c_{2} = 0$.(c)*Two endemic equilibria exists if* $c_{2} > 0$ *that is* $R_{0}^{\prime} < 1$, $c_{1} < 0$ *and* ${c_{1}}^{2} - 4c_{0}c_{2} > 0$(d)*No endemic equilibrium exist other case*.Theorem 3*If* $R_{0}^{\prime} > 1$ *then the endemic equilibrium of the model* (1) *is locally asymptotically stable*.***Proof***: *To prove this theorem we shall use the Krasnoselskii sub linearity trick method* ([@bib15]; [@bib21]). *Here we shall prove that the linearized part of* (1) *around the endemic equilibrium*$E_{1}$ *has no solution of the form*$$\overset{\rightarrow}{Y}\left( t \right) = {\overset{\rightarrow}{Y}}_{0}e^{\omega t}$$*with* ${\overset{\rightarrow}{Y}}_{0} = \left( {Y_{1},Y_{2},Y_{3},Y_{4},Y_{5}} \right),Y_{i},\omega \in C$ *and* ${Re}\left( \omega \right) \geq 0$ *where* $C$ *is the set of complex numbers*.*From the system of* equations [(1)](#fd1){ref-type="disp-formula"} *we consider the following subsystem*:$$\begin{array}{l}
{\frac{dE_{h}}{dt} = \left( {\frac{b_{2}\alpha_{1}I_{v}}{N_{h}} + \frac{c\alpha_{2}I_{h}}{N_{h}}} \right)\left( {N_{h} - E_{h} - I_{h} - R_{h}} \right) - k_{1}E_{h}} \\
{\frac{dI_{h}}{dt} = \sigma E_{h} - k_{2}I_{h}} \\
{\frac{dR_{h}}{dt} = \gamma I_{h} - \mu R_{h} + a\left( {N_{h} - E_{h} - I_{h} - R_{h}} \right)} \\
{\frac{dE_{v}}{dt} = \frac{b_{2}\alpha_{3}I_{h}}{N_{h}}\left( {N_{v} - E_{v} - I_{v}} \right) - k_{3}E_{v}} \\
{\frac{dI_{v}}{dt} = \sigma_{1}E_{v} - \left( {\mu_{1} + b} \right)I_{v}} \\
\end{array}$$*Linearizing* (10) *around the endemic equilibrium* $E_{1}\left( {S_{h}^{\ast},E_{h}^{\ast},I_{h}^{\ast},R_{h}^{\ast},S_{v}^{\ast},E_{v}^{\ast},I_{v}^{\ast}} \right)$ *we get*$$\begin{array}{l}
{\frac{dE_{h}}{dt} = - \left( {\frac{b_{2}\alpha_{1}I_{v}^{\ast}}{N_{h}^{\ast}} + \frac{c\alpha_{2}I_{h}^{\ast}}{N_{h}^{\ast}} + k_{1}} \right)E_{h} - \left( {\frac{b_{2}\alpha_{1}I_{v}^{\ast}}{N_{h}^{\ast}} + \frac{c\alpha_{2}I_{h}^{\ast}}{N_{h}^{\ast}} - \frac{c\alpha_{2}S_{h}^{\ast}}{N_{h}^{\ast}}} \right)I_{h} - \left( {\frac{b_{2}\alpha_{1}I_{v}^{\ast}}{N_{h}^{\ast}} + \frac{c\alpha_{2}I_{h}^{\ast}}{N_{h}^{\ast}}} \right)R_{h}\  + \frac{b_{2}\alpha_{1}S_{h}^{\ast}}{N_{h}^{\ast}}I_{v}} \\
{\frac{dI_{h}}{dt} = \sigma E_{h} - k_{2}I_{h}} \\
{\frac{dR_{h}}{dt} = - aE_{h} + \left( {\gamma - a} \right)I_{h} - \left( {\mu + a} \right)R_{h}} \\
{\frac{dE_{v}}{dt} = \frac{b_{2}\alpha_{3}S_{v}^{\ast}}{N_{h}^{\ast}}I_{h} - \left( {\frac{b_{2}\alpha_{3}I_{h}^{\ast}}{N_{h}^{\ast}} + k_{3}} \right)E_{v} - \frac{b_{2}\alpha_{3}I_{h}^{\ast}}{N_{h}^{\ast}}I_{v}} \\
{\frac{dI_{v}}{dt} = \sigma_{1}E_{v} - \left( {\mu_{1} + b} \right)I_{v}} \\
\end{array}$$*The jacobian of the linear system* (11) *at* $E_{1}$*is*$$J\left( E_{1} \right) = \begin{pmatrix}
{- \left( {\lambda_{h}^{\ast} + k_{1}} \right)} & {J_{2} - \lambda_{h}^{\ast}} & {- \lambda_{h}^{\ast}} & 0 & J_{3} \\
\sigma & {- k_{2}} & 0 & 0 & 0 \\
{- a} & {\gamma - a} & {- \left( {\mu + a} \right)} & 0 & 0 \\
0 & J_{4} & 0 & {- \left( {\lambda_{v}^{\ast} + k_{3}} \right)} & {- \lambda_{v}^{\ast}} \\
0 & 0 & 0 & \sigma_{1} & {- k_{4}} \\
\end{pmatrix}$$where $J_{2} = \frac{c\alpha_{2}S_{h}^{\ast}}{N_{h}^{\ast}},J_{3} = \frac{b_{2}\alpha_{1}S_{h}^{\ast}}{N_{h}^{\ast}},J_{4} = \frac{b_{2}\alpha_{3}S_{v}^{\ast}}{N_{h}^{\ast}}$.*Substitution of a solution of the form* (9) *in the linearized model* (11) *yields the following linear equations*:$$\begin{array}{l}
{\omega Y_{1} = - \left( {\lambda_{h}^{\ast} + k_{1}} \right)Y_{1} + \left( {J_{2} - \lambda_{h}^{\ast}} \right)Y_{2} - \lambda_{h}^{\ast}Y_{3} + J_{3}Y_{5}} \\
{\omega Y_{2} = \sigma Y_{1} - k_{2}Y_{2}} \\
{\omega Y_{3} = - aY_{1} - \left( {a - \gamma} \right)Y_{2} - \left( {\mu + a} \right)Y_{3}} \\
{\omega Y_{4} = J_{4}Y_{2} - \left( {\lambda_{v}^{\ast} + k_{3}} \right)Y_{4} - \lambda_{v}^{\ast}Y_{5}} \\
{\omega Y_{5} = \sigma_{1}Y_{4} - k_{4}Y_{5}} \\
\end{array}$$*Solving for* $Y_{2},Y_{3},Y_{4}$*from second*, *third and fifth equation of* (12) *and then substituting these results into its first and fourth equations we get the following equivalent system*:$$\begin{array}{l}
{\left\lbrack {1 + \frac{1}{k_{1}}\left\{ {\omega + \frac{\lambda_{h}^{\ast}\left( {\omega + \mu} \right)}{\omega + \mu + a} + \frac{\lambda_{h}^{\ast}\sigma}{\omega + k_{2}}.\frac{\omega + \mu + \gamma}{\omega + \mu + a}} \right\}} \right\rbrack Y_{1} = \frac{J_{2}}{k_{1}}Y_{2} + \frac{J_{3}}{k_{1}}Y_{5},\left( {1 + \frac{\omega}{k_{2}}} \right)Y_{2} = \frac{\sigma}{k_{2}}Y_{1}} \\
{\left( {1 + \frac{\omega}{\mu + a}} \right)Y_{3} = - \frac{k_{2} + \sigma + \omega}{\left( {\mu + a} \right)\left( {k_{2} + \omega} \right)}aY_{1} + \frac{\gamma}{\mu + a}Y_{2}} \\
{\left( {1 + \frac{\lambda_{v}^{\ast}\sigma_{1}}{\left( {\omega + k_{4}} \right)\left( {\lambda_{v}^{\ast} + k_{3}} \right)} + \frac{\omega}{\lambda_{v}^{\ast} + k_{3}}} \right)Y_{4} = \frac{J_{4}}{\lambda_{v}^{\ast} + k_{3}}Y_{2},\left( {1 + \frac{\omega}{k_{4}}} \right)Y_{5} = \frac{\sigma_{1}}{k_{4}}Y_{4}} \\
\end{array}$$*Adding the first and third equations of* (13) *and removing the negative term of the left hand side* ([@bib14]) *we get the following system of equations*:$$\left. \begin{array}{l}
{\left\lbrack {1 + G_{1}\left( \omega \right)} \right\rbrack Y_{1} + \left\lbrack {1 + G_{3}\left( \omega \right)} \right\rbrack Y_{3} = \left( {M\overset{\rightarrow}{Y}} \right)_{1} + \left( {M\overset{\rightarrow}{Y}} \right)_{3}} \\
{\left\lbrack {1 + G_{2}\left( \omega \right)} \right\rbrack Y_{2} = \left( {M\overset{\rightarrow}{Y}} \right)_{2}} \\
{\left\lbrack {1 + G_{4}\left( \omega \right)} \right\rbrack Y_{4} = \left( {M\overset{\rightarrow}{Y}} \right)_{4}} \\
{\left\lbrack {1 + G_{5}\left( \omega \right)} \right\rbrack Y_{5} = \left( {M\overset{\rightarrow}{Y}} \right)_{5}} \\
\end{array} \right\}$$where, $G_{1}\left( \omega \right) = \frac{1}{k_{1}}\left\lbrack {\omega + \frac{\lambda_{h}^{\ast}\left( {\omega + \mu} \right)}{\omega + \mu + a} + \frac{1}{k_{2} + \omega}\left\{ {\frac{\lambda_{h}^{\ast}\sigma\left( {\omega + \mu + \gamma} \right)}{\omega + \mu + a} + \frac{ak_{1}\left( {k_{2} + \sigma + \omega} \right)}{\mu + a}} \right\}} \right\rbrack,$$G_{2}\left( \omega \right) = \frac{\omega}{k_{2}},$$G_{3}\left( \omega \right) = \frac{\omega}{\mu + a},$$G_{4}\left( \omega \right) = \frac{1}{\lambda_{v}^{\ast} + k_{3}}\left( {\omega + \frac{\lambda_{v}^{\ast}\sigma_{1}}{\omega + k_{4}}} \right),G_{5}\left( \omega \right) = \frac{\omega}{k_{4}},$ *and* $M = \begin{pmatrix}
0 & m_{1} & 0 & 0 & m_{2} \\
m_{3} & 0 & 0 & 0 & 0 \\
0 & m_{4} & 0 & 0 & 0 \\
0 & m_{5} & 0 & 0 & 0 \\
0 & 0 & 0 & m_{6} & 0 \\
\end{pmatrix}$, *where* $\ m_{1} = \frac{J_{2}}{k_{1}},m_{2} = \frac{J_{3}}{k_{1}},m_{3} = \frac{\sigma}{k_{2}},\ m_{4} = \frac{\gamma}{\mu + a},m_{5} = \frac{J_{4}}{\lambda_{v}^{\ast} + k_{3}},m_{6} = \frac{\sigma_{1}}{k_{4}}.$*Here the notation*$\left( {M\overset{\rightarrow}{Y}} \right)_{i}$*represent the i-th co-ordinate of the vector*$\left( {M\overset{\rightarrow}{Y}} \right)$~.\ *It\ should\ be\ noted\ that\ the\ matrix*~ $M$ ~*has\ non-negative\ entries\ and\ the\ endemic\ equilibrium*~ $E_{1} = \left( {E_{h}^{\ast},I_{h}^{\ast},R_{h}^{\ast},E_{v}^{\ast},I_{v}^{\ast},I_{v}^{\ast}} \right)$ ~*satisfies*~ $E_{1} = ME_{1}$. *If* $Y$*is a solution of* (14) *then it is possible to find a minimal positive number* $r$*such that*$$\left| \bar{Y} \right| \leq rE_{1}$$*where* $\left| \bar{Y} \right| = \left( {\left| Y_{1} \right|,\left| Y_{2} \right|,\left| Y_{3} \right|,\left| Y_{4} \right|,\left| Y_{5} \right|} \right)$. *Here the number*$r$*is also the minimal positive number that satisfies the inequality* $\left| Y_{1} \right| + \left| Y_{3} \right| \leq r\left( {E_{h}^{\ast} + R_{h}^{\ast}} \right)$. *We want to show that* ${Re}\left( \omega \right) < 0$. *On the contrary we assume* ${Re}\left( \omega \right) \geq 0$ *and we consider the two cases*: $\omega = 0$ *and* $\omega \neq 0$.*In first case*$\omega = 0$ *the system of* equations [(12)](#fd12){ref-type="disp-formula"} *is homogeneous linear system of equations*. *It is clear that the coefficient determinant* $\Delta$ *is non zero and consequently the system* (12) *has the unique solution* $\bar{Y} = \bar{0}$*which corresponds to the disease free steady state of the system* (1).*Next we consider the second case* $\omega \neq 0$. *By the assumption* ${Re}\left( \omega \right) \geq 0$, *we have* ${Re}G_{i}\left( \omega \right) \geq 0,\left( {i = 1,2,3,4,5} \right)$ *which implies that* $\left| {1 + G_{i}\left( \omega \right)} \right| > 1$ *for all*$i$. *Let us now define* $G\left( \omega \right) = \min\left| {1 + G_{i}\left( \omega \right)} \right|,i = 1,2,3,4,5$.*Then* $G\left( \omega \right) > 1$ *or equivalently* $\frac{r}{G\left( \omega \right)} < r$. *The property of minimality of* $r$ *implying* $\left| \bar{Y} \right| > \frac{r}{G\left( \omega \right)}E_{1}$. *Now taking norms of both sides of the second equation of* (14) *we get*$$G\left( \omega \right)\left| Y_{2} \right| \leq M\left( \left| Y \right| \right)_{2} \leq r\left( {M\left| E_{1} \right|} \right)_{2} \leq rI_{h}^{\ast}$$*This inequality implies* $\left| Y_{2} \right| \leq \frac{r}{G\left( \omega \right)}I_{h}^{\ast}$ *which contradicts*. *Hence* ${Re}\left( \omega \right) < 0$. *Thus the real parts of all eigenvalues of the characteristic equation of the linear system* (1) *will be negative*. *So* $E_{1}$ *is locally asymptotically stable*.

3.4. Backward bifurcation {#sec3.3}
-------------------------

In this section we shall study the possibility of a backward bifurcation in the zika model (1) using centre manifold theorem as discussed by in Castillo-Chavez and Song ([@bib7]).Theorem 4*The model* (1) *undergoes backward bifurcation at* $R_{0}^{\prime} = 1$ *whenever the sign of the coefficient* $a^{\prime}$ *is positive where* $a^{\prime}$*is defined in* (18).***Proof***: *We redefine the model* (1) *by changing the variables*:*Let* $S_{h} = x_{1},E_{h} = x_{2},I_{h} = x_{3},R_{h} = x_{4},S_{v} = x_{5},E_{v} = x_{6},I_{v} = x_{7}$. *So that*$$N_{h} = x_{1} + x_{2} + x_{3} + x_{4},N_{v} = x_{5} + x_{6} + x_{7}$$*Applying vector notation* $\overset{\rightarrow}{x} = \left( {x_{1},x_{2},x_{3},x_{4},x_{5},x_{6},x_{7}} \right)^{T}$*the model* (1) *can be written as*$\frac{d\overset{\rightarrow}{x}}{dt} = \overset{\rightarrow}{f}\left( \overset{\rightarrow}{x} \right)$ where $\overset{\rightarrow}{f} = \left( {f_{1},f_{2},f_{3},f_{4},f_{5},f_{6},f_{7}} \right)^{T}$ as follows:$$\begin{array}{l}
{\frac{dx_{1}}{dt} = f_{1} = \pi - \left( \frac{b_{2}\alpha_{1}x_{7} + c\alpha_{2}x_{3}}{x_{1} + x_{2} + x_{3} + x_{4}} \right)x_{1} - \left( {\mu + a} \right)x_{1}} \\
{\frac{dx_{2}}{dt} = f_{2} = \left( \frac{b_{2}\alpha_{1}x_{7} + c\alpha_{2}x_{3}}{x_{1} + x_{2} + x_{3} + x_{4}} \right)x_{1} - \left( {\sigma + \mu} \right)x_{2}} \\
{\frac{dx_{3}}{dt} = f_{3} = \sigma x_{2} - \left( {\gamma + \mu} \right)x_{3}} \\
{\frac{dx_{4}}{dt} = f_{4} = \gamma x_{3} - \mu x_{4} + ax_{1}} \\
{\frac{dx_{5}}{dt} = f_{5} = \pi_{1} - \frac{b_{2}\alpha_{3}x_{3}x_{5}}{x_{1} + x_{2} + x_{3} + x_{4}} - \left( {\mu_{1} + b} \right)x_{5}} \\
{\frac{dx_{6}}{dt} = f_{6} = \frac{b_{2}\alpha_{3}x_{3}x_{5}}{x_{1} + x_{2} + x_{3} + x_{4}} - \left( {\sigma_{1} + \mu_{1} + b} \right)x_{6}} \\
{\frac{dx_{7}}{dt} = f_{7} = \sigma_{1}x_{6} - \left( {\mu_{1} + b} \right)x_{7}} \\
\end{array}$$*For the above system the disease free equilibrium* (*DFE*) $E_{0}^{\prime}$ *given by*$E_{0}^{\prime} = \left( {x_{1}^{0},0,0,x_{4}^{0},x_{5}^{0},0,0} \right)$ *where* $x_{1}^{0} = \frac{\pi}{\mu + a},x_{4}^{0} = \frac{a\pi}{\mu\left( {\mu + a} \right)},x_{5}^{0} = \frac{\pi_{1}}{\mu_{1} + b}$*The jacobian matrix of the above system at the disease free equilibrium* $E_{0}$ *is given by*$$J\left( E_{0} \right) = \begin{pmatrix}
{- \left( {\mu + a} \right)} & 0 & {- \lambda_{2}^{0}x_{1}^{0}} & 0 & 0 & 0 & {- \lambda_{1}^{0}x_{1}^{0}} \\
0 & {- k_{1}} & {\lambda_{2}^{0}x_{1}^{0}} & 0 & 0 & 0 & {\lambda_{1}^{0}x_{1}^{0}} \\
0 & \sigma & {- k_{2}} & 0 & 0 & 0 & 0 \\
a & 0 & \gamma & {- \mu} & 0 & 0 & 0 \\
0 & 0 & {- \lambda_{v}^{0}x_{5}^{0}} & 0 & {- k_{4}} & 0 & 0 \\
0 & 0 & {\lambda_{v}^{0}x_{5}^{0}} & 0 & 0 & {- k_{3}} & 0 \\
0 & 0 & 0 & 0 & 0 & \sigma_{1} & {- k_{4}} \\
\end{pmatrix}.$$*Taking* $\alpha_{3}$ *as a bifurcation parameter we found* $R_{0}^{\prime}\left( {\alpha_{3} = \alpha_{3}^{\ast}} \right) = 1$, *which gives*. *The jacobian of the transformed model* (17) *at the disease free equilibrium at* $\alpha_{3} = \alpha_{3}^{\ast}$ *has a simple zero eigenvalue and all other eigenvalues have negative real part*. *So the centre manifold theory can be used to study the dynamics of the model* (17) *near* $\alpha_{3} = \alpha_{3}^{\ast}$.*In particular we will use the theorem given by Castillo-Chavez and Song* ([@bib7]). *The necessary computation for the theorem given bellow*:*The right eigenvector*:*The right eigenvector of the jacobian associated with zero eigenvalue at*$\alpha_{3} = \alpha_{3}^{\ast}$ *is given by*: $W = \left( {w_{1},w_{2},w_{3},w_{4},w_{5},w_{6},w_{7}} \right)^{T}$where, $w_{1} = - \left( {\frac{c\alpha_{2}k_{3}k_{4}\left( {\mu_{1} + b} \right)}{\sigma_{1}b_{2}\alpha_{3}^{\ast}\pi_{1}} + \frac{b_{2}\alpha_{1}\mu}{\pi}} \right)\frac{\pi}{\left( {\mu + a} \right)^{2}},w_{2} = \frac{k_{2}k_{3}k_{4}\left( {\mu_{1} + b} \right)\pi}{\sigma\sigma_{1}b_{2}\alpha_{3}^{\ast}\mu\pi_{1}},w_{3} = \frac{k_{3}k_{4}\pi\left( {\mu_{1} + b} \right)}{\sigma_{1}b_{2}\alpha_{3}^{\ast}\mu\pi_{1}},$$$w_{4} = \frac{1}{\mu}\left( {w_{3}\gamma + aw_{1}} \right),w_{5} = - \frac{k_{3}}{\sigma_{1}},w_{6} = \frac{k_{4}}{\sigma_{1}},w_{7} = 1 > 0$$*The left eigenvector of the jacobian matrix associated with zero eigenvalue at*$\alpha_{3}^{\ast}$ *is given by*$V = \left( {0,v_{2},v_{3},0,0,v_{6},1} \right)$ where $v_{2} = \frac{k_{4}\left( {\mu + a} \right)}{b_{2}\alpha_{1}\mu},v_{3} = \frac{k_{1}k_{4}\left( {\mu + a} \right)}{ab_{2}\alpha_{1}\mu}$ , $v_{6} = \frac{\sigma_{1}}{k_{3}} > 0$. *The bifurcation coefficients* $a^{\prime}$*and*$b^{\prime}$*are given by* $\begin{array}{l}
{a^{\prime} = \sum\limits_{k,i,j = 1}^{7}{v_{k}w_{i}w_{j}\frac{\partial^{2}f_{k}}{\partial x_{i}\partial x_{j}} = v_{2}\sum\limits_{i,j = 1}^{7}{w_{i}w_{j}\frac{\partial^{2}f_{2}}{\partial x_{i}\partial x_{j}}}}} \\
{\ \ \ \ \ \ \ \ \ \  + v_{3}\sum\limits_{i,j = 1}^{7}{w_{i}w_{j}\frac{\partial^{2}f_{3}}{\partial x_{i}\partial x_{j}} + v_{6}\sum\limits_{i,j = 1}^{7}{w_{i}w_{j}\frac{\partial^{2}f_{6}}{\partial x_{i}\partial x_{j}}} + v_{7}\sum\limits_{i.j = 1}^{7}{w_{i}w_{j}\frac{\partial^{2}f_{7}}{\partial x_{i}\partial x_{j}}}}} \\
\end{array}$where $\begin{array}{l}
{\frac{\partial^{2}f_{2}}{\partial x_{3}\partial x_{1}} = \frac{\partial^{2}f_{2}}{\partial x_{1}\partial x_{3}} = \frac{c\alpha_{2}\mu a}{\pi\left( {\mu + a} \right)},\frac{\partial^{2}f_{2}}{\partial x_{7}\partial x_{1}} = \frac{\partial^{2}f_{2}}{\partial x_{1}\partial x_{7}} = \frac{b_{2}\alpha_{1}\mu a}{\pi\left( {\mu + a} \right)},\frac{\partial^{2}f_{2}}{\partial x_{7}\partial x_{2}} = \frac{\partial^{2}f_{2}}{\partial x_{2}\partial x_{7}} = \frac{\partial^{2}f_{2}}{\partial x_{7}\partial x_{3}} = \frac{\partial^{2}f_{2}}{\partial x_{3}\partial x_{7}}} \\
{= \frac{\partial^{2}f_{2}}{\partial x_{7}\partial x_{4}} = \frac{\partial^{2}f_{2}}{\partial x_{4}\partial x_{7}} = - \frac{b_{2}\alpha_{1}\mu^{2}}{\pi\left( {\mu + a} \right)},\frac{\partial^{2}f_{2}}{\partial x_{3}\partial x_{2}} = \frac{\partial^{2}f_{2}}{\partial x_{2}\partial x_{3}} = \frac{\partial^{2}f_{2}}{\partial x_{4}\partial x_{3}} = \frac{\partial^{2}f_{2}}{\partial x_{3}\partial x_{4}} = - \frac{c\alpha_{2}\mu^{2}}{\pi\left( {\mu + a} \right)},\frac{\partial^{2}f_{2}}{\partial x_{3}^{2}} = - \frac{2c\alpha_{2}\mu^{2}}{\pi\left( {\mu + a} \right)}} \\
{\frac{\partial^{2}f_{6}}{\partial x_{3}\partial x_{1}} = \frac{\partial^{2}f_{6}}{\partial x_{1}\partial x_{3}} = \frac{\partial^{2}f_{6}}{\partial x_{3}\partial x_{2}} = \frac{\partial^{2}f_{6}}{\partial x_{2}\partial x_{3}} = \frac{\partial^{2}f_{6}}{\partial x_{4}\partial x_{3}} = \frac{\partial^{2}f_{6}}{\partial x_{3}\partial x_{4}} = \frac{1}{2}\frac{\partial^{2}f_{6}}{\partial x_{3}^{2}} = - \frac{b_{2}\alpha_{3}^{\ast}\pi_{1}\mu^{2}}{\left( {\mu + b} \right)\pi^{2}},\frac{\partial^{2}f_{6}}{\partial x_{5}\partial x_{3}} = \frac{\partial^{2}f_{6}}{\partial x_{3}\partial x_{5}} = \frac{b_{2}\alpha_{3}^{\ast}\mu}{\pi}.} \\
\end{array}$and all others derivatives are zero so that$$\begin{array}{l}
{a^{\prime} = \frac{2k_{4}ar_{2}}{b_{2}\alpha_{1}\pi}\left( {rc\alpha_{2} + b_{2}\alpha_{1}} \right) + \frac{2\mu\sigma_{1}rr_{2}\alpha_{3}^{\ast}\pi_{1}}{\left( {\mu_{1} + b} \right)\pi^{2}k_{3}}\left( {b_{2}\mu + a} \right) - \frac{2k_{4}}{\pi b_{2}\alpha_{1}}\left( \begin{array}{l}
{rr_{2}c\alpha_{2}a + r_{2}b_{2}\alpha_{1}a + rr_{3}c\alpha_{2}\mu + r_{3}b_{2}\alpha_{1}\mu + r^{2}c\alpha_{2}\mu +} \\
{r^{2}c\alpha_{2}\gamma + rb_{2}\alpha_{2}\mu + r\gamma b_{2}\alpha_{1}} \\
\end{array} \right)} \\
{\ \ \ \ \ \ \ \ \ \ \ \ \frac{2\mu\sigma_{1}r\alpha_{3}^{\ast}}{\left( {\mu_{1} + b} \right)\pi^{2}k_{3}}\left( {r_{3}b_{2}\pi_{1}\mu + rb_{2}\pi_{1}\mu + r\gamma b_{2}\pi_{1} + \frac{k_{3}}{\sigma}\pi\left( {\mu_{1} + b} \right)b_{2}\alpha} \right)} \\
\end{array}$$the value of $b^{\prime} = \sum\limits_{k,i = 1}^{7}{v_{k}w_{i}\frac{\partial^{2}f_{k}}{\partial x_{i}\partial\alpha_{3}^{\ast}} = v_{6}\sum\limits_{i = 1}^{7}{w_{i}\frac{\partial^{2}f_{6}}{\partial x_{i}\partial\alpha_{3}^{\ast}}}}$ as $\frac{\partial f_{k}}{\partial\alpha_{3}^{\ast}} = 0,k = 1,2,3,4,7\ and\ v_{5} = 0$ and the only non-zero derivative is $\frac{\partial^{2}f_{6}}{\partial x_{3}\partial\alpha_{3}^{\ast}} = \frac{b_{2}\pi_{1}\mu}{\pi\left( {\mu_{1} + b} \right)}$. *Therefore* $b^{\prime} = \frac{\sigma_{1}rb_{2}\pi_{1}\mu}{k_{3}\pi\left( {\mu_{1} + b} \right)} > 0$.*Hence the model* (1) *undergoes backward bifurcation at* $R_{0}^{\prime} = 1$ *whenever* $a^{\prime} > 0$.*In backward bifurcation a stable disease free equilibrium* (*DFE*) *co-exists with two endemic equilibrium* (*EE*) *among which one is unstable and other one is stable when* $R_{0}^{\prime} < 1$.*The biological significance of the backward bifurcation phenomenon of the zika model* (1) *is that the condition* $R_{0}^{\prime} < 1$ *for elimination of zika from population is the necessary condition but not sufficient*, *in that case elimination of zika depend on initial sizes of the population that fact is present in* [Fig. 2](#fig2){ref-type="fig"}.Fig. 2*Backward bifurcation diagram of the modified zika model* (17) *for*: (*a*) *infected human* (*b*) *infected mosquito population using the parameter values*$\pi = 3.3,\pi_{1} = 1000,\mu = 0.8,\mu_{1} = 0.35,\alpha_{1} = 0.4,\sigma_{1} = 2/7$*and the values of the other parameters presented in*[Table 3](#tbl3){ref-type="table"}.Fig. 2

4\. *Model fitting to the Zika infected data in Colombia*: *Parameter Estimation and Model validation*

*In this section we have validated the considered Zika model* (1) *considering the reported Zika infected human data of* 1 *to* 36 *weeks* 2016 *in Colombia which is given in* [Table 2](#tbl2){ref-type="table"}. *The data has been provided by National Institute of Health SIVIGILA*, *Colombia which also has been used in literature* ([@bib3]). *We found the best fitted model parameters for the considered model* (1) *with the above said data by using MATLAB minimization software package fmincon*. *In order to fit the model* (1) *to the weekly reported Zika infected data in Colombia to the year* 2016 *we considered the initial susceptible human as* 19471223 *and the initial number of infected populations as* 2173 *as reported in* ([@bib3]) *and initial density of the other populations we assume arbitrarily*. *Similarly*, *some model parameters are assumed arbitrarily and then using the MATLAB minimization software package the remaining parameters have been estimated and those values summarized in* [Table 3](#tbl3){ref-type="table"}.Table 2*The weekly reported data of Zika infection cases in Colombia from* 1 *to* 36 *week of* 2016 *provided by National Institute of Health SIVIGILA*, *which also used in* ([@bib3]).Table 2*WeekCasesWeekCasesWeekCasesWeekCases*121731026551932812870524105112639206382964834166123882211567304964466913380822201431416541981430592315393221564316153364241344333017546016267125112834271828651726652699135568937671826872789236383

*In* [Fig. 3](#fig3){ref-type="fig"} *we have plotted the reported Zika infection data in Colombia from* 1 *to* 36 *week of* 2016 *using blue dots and considering the estimated model parameters we have predicted the density of the infected populations up to* 80 *weeks*. *It is clear from the prediction of the solution curve that the disease will no longer out break after* 50 *weeks in Colombia*, *which is supported by the reported real cases in the same region by WHO* ([@bib39]) . *Our model we predict that there will be* 113 *average weekly cases during* 37 *to* 52 *week of the year* 2016 *which is close to* 130 *reported real cases by WHO* ([@bib39]). *According to our model prediction zika will be eradicated from Colombia on or after* 28 *week of* 2017 *which also supported by real data* ([@bib39]).Fig. 3*The reported infected populations* (*the blue dots*) *and the best*. *fitted solution* (*solid red curve*) *the model* (1).Fig. 3

*The theoretical finding in Lemma-*3, 4 *and theorem-*1*are graphically verified considering the model parameters as given* [Table 3](#tbl3){ref-type="table"} (*see* [Fig. 4](#fig4){ref-type="fig"}). *For these values of the parameters the value of basic reproduction number is less than unity*. *Hence the disease free equilibrium point is globally asymptotically stable for these parametric values*. *In* [Fig. 4](#fig4){ref-type="fig"} *we have presented the time series of* $I_{h},$ *and* $I_{v}$ *for different initial values of the populations*. *It is clear that if the system starts for different initial points then it will ultimately converge to* $I_{h} = 0$*and* $I_{v} = 0$*respectively*. *Thus from the* [Fig. 4](#fig4){ref-type="fig"} *it clear that system is locally as well globally asymptotically stable if the condition stated in the corresponding lemmas and theorem is satisfied*.Table 3Parameter values and their Sensitivity indices of the model (1) with respect to.$R_{0}^{\prime}.$Table 3ParameterValuesSourceSensitivity index$b_{2}$0.45[@bib1], [@bib2]1.99928242$\mu$0.00019204Estimated1.01880565$\pi_{1}$100Assume0.99964121$\alpha_{1}$0.04441746Estimated0.99964121$\alpha_{3}$0.04791129Estimated0.99964121$\sigma_{1}$0.02070591Estimated0.50624931$\sigma$0.35808521Estimated$5.36009473 \times 10^{- 04}$$\alpha_{2}$0.03362689Estimated$3.58792179 \times 10^{- 04}$$c$0.00552894Estimated$3.58792179 \times 10^{- 04}$$\pi$0.01747[@bib23]−0.99964121$\gamma$0.07098011Estimated−0.99730175$a$0.00000440Estimated−0.02239870$\mu_{1}$0.02053120Estimated--$1.92341903 \times 10^{- 06}$$b$0.00071429Assume--$6.69166430 \times 10^{- 08}$Fig. 4*Time series for* (*a*) *infected human*$I_{h}$*and* (*b*) *infected mosquito*$I_{v}$*populations for the parameters given in*[Table 3](#tbl3){ref-type="table"}*with different initial conditions for the model* (1).Fig. 4

*Since the system contains fourteen parameters among them some parameters are highly sensitive*. *A small change of the parameters will affect highly the system*. *In this next section using sensitivity analysis we shall determine the highly sensitive parameters*.

5. Sensitivity analysis {#sec4}
=======================

Using sensitivity analysis we shall determine the parameters those have high significant impact on the threshold number $R_{0}^{\prime}$ of the zika model (1). Such analysis tells us the importance of each parameter on disease transmission and this will help the public helth authorities to place of priority for prevention and controlling the spread of the zika virus in the human population. Such information is also important for experimental design, data assimilation and reduction of complex nonlinear model ([@bib32]).

In order to perform such analysis we shall use the normalised forward sensitivity index of a variable with respect to a parameter which is expressed as the ratio of the relative variation in the variable to the relative variation in the parameter. The sensitivity index can be defined using partial derivatives.Definition 4.1The normalised forward sensitivity index of $R_{0}^{\prime}$ that depends differentiably on a parameter $l$ is defined by $\gamma_{l}^{R_{0}^{\prime}} = \frac{\partial R_{0}^{\prime}}{\partial l}.\frac{l}{R_{0}^{\prime}}$ ([@bib10]).Using the explicit expression of$R_{0}^{\prime}$ in the above sensitivity index formula we have derived an expression for the sensitivity of $R_{0}^{\prime}$ with respect to each parameter. Then using the base line values of parameters, given in [Table 3](#tbl3){ref-type="table"} we have estimated the numerical values for the sensitivity index and the results are also summarised in [Table 3](#tbl3){ref-type="table"}.A small variation in a most sensitive parameter will create large quantitative variation. Thus it should be carefully estimated whether a small variation in a least sensitive parameter will not create large variation so it need not require too much effort to estimate such least sensitive parameters.[Table 3](#tbl3){ref-type="table"} presents the base line value of parameters used for the numerical simulation and it also shows the sensitivity indices of the zika model with respect to$R_{0}^{\prime}$. From [Table 3](#tbl3){ref-type="table"} it is clear that the mosquito biting rate $b_{2}$ is the most sensitive parameter with sensitivity index 1.999 which indicates that increase (or decrease) the mosquito biting rate $b_{2}$ by 10% will be followed by an immediate increase (or decrease) in $R_{0}^{\prime}$ by 19.99%. Similarly increase (or decrease) of the parameters $\pi_{1},\alpha_{1},\alpha_{3},\sigma_{1}$ by 10% will be followed by an immediate increase (or decrease) in $R_{0}^{\prime}$ by 9.99%, 9.99%, 9.99%, 5.56% respectively.Though the recruitment rate of human has the most negative sensitivity index but in the epidemiological context the important parameters which have negative sensitivity indices are $\gamma,a,\mu_{1},b$. The significance of negative sensitivity indices of the above said parameters are increase (or decrease) in the parameters $\gamma,a$ by 10% will be followed by an immediate decrease (or increase) in $R_{0}^{\prime}$ by 9.97%, 0.224% respectively. In summary, the zika sensitivity analysis identifies the most important parameters driving the transmission mechanism of the zika virus. The results suggest that a control strategy that reduces the mosquito biting rate, recruitment rate of mosquito, transmission probability per biting of susceptible humans by infected mosquito, transmission probability per biting of susceptible mosquito with infected humans, progression rate from exposed to infected mosquito, progression rate from exposed to infected human, transmission probability per sexual contact among a susceptible and infected human and sexual contact rate between a susceptible human to an infected human ($b_{2},\pi_{1},\alpha_{1},\alpha_{3},\sigma_{1},\sigma,\alpha_{2},c$) respectively and the control strategy that increase rate of recovery rate of infected human, awareness in host population, death rate of mosquito and constant rate of effective mosquito control ($\gamma,a,\mu_{1},b$) will effectively resist the spread of zika virus in the human population.Now, to verify the sensitive parameters we have plotted the solution curve for the number of infected and exposed humans for different values of the model parameters keeping the initial conditions same. To simulate the system numerically we have to use the estimated model parameter as presented in [Table 3](#tbl3){ref-type="table"} with the initial conditions: $S_{h}\left( 0 \right) = 1000,E_{h}\left( 0 \right) = 06,I_{h}\left( 0 \right) = 04,$ $R_{h}\left( 0 \right) = 00,$ $S_{v}\left( 0 \right) = 4000,$ $E_{v}\left( 0 \right) = 500,I_{v}\left( 0 \right) = 100$.The time series of exposed human and the infectious human are plotted in [Fig. 5](#fig5){ref-type="fig"}(a) and (b) respectively for different values of mosquito biting rate ($b_{2}$). It is clear from the figures that the number of both class increases due to the increase (decrease) in $b_{2}$. Thus the mosquito bite rate plays an important role to spreads the zika virus.Fig. 5Time series of the model (1) for the different values of $b_{2}$ of (a) Exposed human population (b) infected human population, other parameter values presented in [Table 3](#tbl3){ref-type="table"}.Fig. 5

The effect of sexual contact rate ($c$) between a susceptible human and an infected human on exposed and infectious human population has been presented in [Fig. 6](#fig6){ref-type="fig"}(a) and (b) respectively. It is clear from [Fig. 6](#fig6){ref-type="fig"}(a and b) that due to increase or decrease of sexual contact rate ($c$) both the exposed and infectious human population increases or decreases.Fig. 6Time series presenting the effect of Sexual contact rate $c$ between a susceptible human to an infected human on the (a) exposed human and (b) infected human, using the parameter values presented in [Table 3](#tbl3){ref-type="table"}.Fig. 6

The effect of human awareness rate ($a$) on zika transmission dynamics among human presented in [Fig. 7](#fig7){ref-type="fig"}(a and b). From these two figures it is clear that increase of human awareness decreases both exposed and infectious human population and vice-versa.Fig. 7Time series of Zika model (1) for different values of human awareness $a$ and other parameter values presented in [Table 3](#tbl3){ref-type="table"}: (a) exposed human and (b) infected human.Fig. 7

In [Fig. 8](#fig8){ref-type="fig"} we have presented the time series of exposed human and infected human for different values of vector control ($b$). It is clear from the figure that both the exposed human population and infectious human population decrease as the vector control increase.Fig. 8Time series of the Zika model (1) showing the effect of vector control $b$ on the (a) exposed human and (b) infected human using the parameter values presented in [Table 3](#tbl3){ref-type="table"}.Fig. 8

Thus from the above series of time series analysis it is clear that the amount of exposed and infected human population decrease when the vector biting rate ($b_{2}$), the sexual contact rate ($c$) among susceptible human to infected human decrease and the human awareness rate $\left( a \right)$ the vector control rate ($b$) increase. Considering above said four facts simultaneously as a precautionary measures we presents the behaviour of the infected human population in [Fig. 9](#fig9){ref-type="fig"}. The figure shows that the number of infected human population decreases when the vector biting rate and the sexual contact rate decreases and the human awareness rate and the vector control rate increases simultaneously over a period of time.Fig. 9Time series of the zika model (1) presenting the effect of vector biting rate, sexual contact rate, human awareness and vector control simultaneously on the behaviour of the infected human population. The solid line graphics obtained using the parameter values $b_{2} = 0.45,c = 0.00552894,a = 0.0000044,b = 0.00071429$ and the dashed line graphics obtained by using the parameter values $a = 0.0000088,$$b_{2} = 0.4,c = 0.001382235,$$b = 0.00214287$ the other parameter values presented in [Table 3](#tbl3){ref-type="table"}.Fig. 9

6. Effect of sexual transmission on epidemic growth rate and basic reproduction number {#sec5}
======================================================================================

In this section we have established the effect of sexual transmission to the epidemic growth rate as well as basic reproduction number. In deterministic epidemic model the disease free equilibrium (DFE) locally stable if the basic reproduction number $R_{0}^{\prime} < 1$ and unstable if $R_{0}^{\prime} > 1$ ([@bib37]) and for $R_{0}^{\prime} > 1$ disease outbreak occurs. The dominant eigen value of the jacobian matrix at the disease free equilibrium (DFE) is the initial outbreak growth rate ($r$). In our model the dominant eigenvalue of the jacobian matrix at the DFE is the dominant root of the corresponding characteristic equation [(4)](#fd4){ref-type="disp-formula"}. It is a four degree equation, so it is not easy to find the explicit expression of the dominant root *i.e.*to find the initial epidemic growth rate of the model. So, we shall establish the effect of sexual transmission on epidemic growth rate and basic reproduction number numerically. In [Fig. 10](#fig10){ref-type="fig"}(a) and (b) we have presented the effect of $\alpha_{2}$ on the basic reproduction number $R_{0}$ and the epidemic growth rate $r$ respectively. [Fig. 10](#fig10){ref-type="fig"}(a and b) show that the basic reproduction number and the epidemic growth rate both increase with the increase of the transmission probability per sexual contact between susceptible and infected human.Fig. 10Presents the effect of $\alpha_{2}$ on (a) the basic reproduction number $R_{0}$ and on (b) the epidemic growth rate $r$ using the parameter values $\pi = 0.08547,c = 0.4$ and the values of the others parameter presented in [Table. 3](#tbl3){ref-type="table"}.Fig. 10

7. Conclusion {#sec6}
=============

In this work, we have developed and analyzed a deterministic ODE model for Zika virus transmission dynamics that incorporates both mosquito and sexual transmission paths, which also includes vector control and human awareness. The positivity and boundedness of the proposed model are investigated here. We obtained the basic reproduction number by next-generation matrix technique. The steady-state analysis shows that the disease-free equilibrium (DFE) is and globally asymptotically stable if the basic reproduction number $R_{0}^{\prime}$ less than unity. The conditions for the existence of endemic equilibrium of the model are obtained. Using the Krasnoselskii sub linearity trick method we have established that the endemic equilibrium is locally asymptotically stable if the basic reproduction number $R_{0}^{\prime}$ is greater than one. Under some condition the model exhibits the phenomenon of backward bifurcation. The biological significance of this result is that the condition reproduction number less than unity for the elimination of zika virus from the population is the necessary condition but not sufficient. We estimate the model parameters and validate the model by using the reported Zika infection data in Colombia of the year 2016.

The effect of sexual transmission both on basic reproduction number and epidemic growth rate have been established numerically which shows that with the increase of sexual transmission rate the density of exposed and infected populations both increases. So we can control zika virus by controlling sexual transmission rate. Sensitivity and numerical analyses were done to determine the impact of the parameters on the zika infection. The most effective parameters were found the mosquito biting rate, recruitment rate of mosquito, transmission probability per biting of a susceptible human with an infected mosquito, the rate of the awareness host population and the recovery rate of the infected human population. This model will help the public health planar to frame a policy for controlling Zika. In further, we will extend the model incorporating the optimal control theory.
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